Inventor
FREDERIC TREMBLAY
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C12NMicroorganisms or enzymes31%
C12YEnzymes8%
PatentTitleYear
12,522,822Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof202612,480,125Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof202512,404,508Ketohexokinase (KHK) iRNA compositions and methods of use thereof202512,359,20117ss-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof202511,926,832Ketohexokinase (KHK) iRNA compositions and methods of use thereof202411,180,75717b-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof202111,162,103Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof202111,149,276Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ALNYLAM PHARMACEUTICALS INC (6)· patent assignee history
2021–2025Patents assigned to REGENERON PHARMA (2)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 6 | 2021–2026 |
| REGENERON PHARMA | 2 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2026 |